Erik Schneider

Erik Schneider is an accomplished professional in process development, currently serving as Associate Director of Process Development at Krystal Biotech, Inc. since October 2020, with prior roles including Senior Manager of Downstream Process Development and Process Validation Engineer. At Regeneron Pharmaceuticals, Inc., from February 2016 to October 2020, Erik contributed significantly to virus retentive filtration and unit operations for multiple late-stage programs, employing advanced statistical analysis to optimize process attributes. Erik's experience includes collaborative roles across various companies, such as Penn State University and Mars, where key projects led to substantial efficiency improvements and cost savings. Erik holds a Bachelor of Science in Chemical Engineering from Penn State University, augmented by academic experience at The University of Auckland.